Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma

BACKGROUND/AIMS: Chronic hepatitis C (CHC) treatment has dramatically improved since direct-acting antiviral (DAA) therapy was introduced. However, the use of DAA therapy in CHC patients with hepatocellular carcinoma (HCC) remains controversial. We investigated the DAA treatment response in CHC pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwan, Byung Soo, Kim, Jeong Han, Park, Seong Jun, Choe, Won Hyeok, Kwon, So Young, Yoo, Byung-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969069/
https://www.ncbi.nlm.nih.gov/pubmed/32241083
http://dx.doi.org/10.3904/kjim.2019.297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969069/
https://www.ncbi.nlm.nih.gov/pubmed/32241083
http://dx.doi.org/10.3904/kjim.2019.297

Ejemplares similares